Search Grant Opportunities

DoD Peer Reviewed Cancer, Idea Award

ID: HT942524PRCRPIA • Type: Posted

Description

The FY24 PRCRP Idea Award supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or basic cancer research. The advancement of knowledge in cancer research, patient care, and/or treatment options in the MHS is critical to active-duty Service Members, Veterans, other military beneficiaries, and the American public.

The intention of the Idea Award is innovative basic research that may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. The Idea Award is not intended to support a logical progression of an already established research project in a laboratory. Incremental advances, the next logical step, or switching a model system from one cancer to another cancer are not considered innovative. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design and generate robust preliminary data that can be used as a foundation for future research projects.

Inclusion of preliminary data is discouraged. This award is not intended to support ongoing research in the applicant's laboratory; therefore, inclusion of preliminary data is not consistent with the exploratory nature of this award.

It is the responsibility of the Principal Investigator (PI) to select the funding opportunity that is most appropriate for the research proposed. Advanced research with robust preliminary data is more appropriate for the FY24 PRCRP Impact Award (HT942524PRCRPIPA).

Background
The FY24 PRCRP Idea Award supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or basic cancer research. The goal of the PRCRP is to improve mission readiness and quality of life by decreasing the burden of cancer on Service Members, their Families, Veterans, and the American public.

Grant Details
The U.S. Army Medical Research Acquisition Activity (USAMRAA) is soliciting applications to the fiscal year 2024 (FY24) Peer Reviewed Cancer Research Program (PRCRP) using delegated authority provided by United States Code, Title 10, Section 4001 (10 USC 4001). The Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC) is the program management agent for this funding opportunity. The proposed research must be relevant to active-duty Service Members, Veterans, military beneficiaries, and/or the American public.
Applications for the FY24 PRCRP Idea Award must address at least one of the congressionally directed FY24 PRCRP Topic Areas and define how the research is relevant to Service Members and their Families by addressing at least one of the FY24 PRCRP Military Health Focus Areas.

Eligibility Requirements
Extramural and Intramural organizations are eligible to apply, including foreign or domestic organizations, for-profit and non-profit organizations, and public entities. The Principal Investigator (PI) must have a faculty-level appointment or equivalent. Cost sharing/matching is not an eligibility requirement.

Period of Performance
Awards supported with FY24 funds will be made no later than September 30, 2025. The CDMRP expects to allot approximately $16M to fund approximately 20 Idea Award applications.
Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

Grant Value
$400,000 is the anticipated direct costs budgeted for the entire period of performance for an FY24 PRCRP Idea Award. The FY24 appropriation is $130M.
Show All

Overview

Agency
U.S. Army Medical Research Acquisition Activity (USAMRAA) [DoD - USA - MEDCOM - MRDC]
Category of Funding
Science and Technology and other Research and Development
Funding Instruments
Grant
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
Grants.gov
On 5/1/24 U.S. Army Medical Research Acquisition Activity posted grant opportunity HT942524PRCRPIA for DoD Peer Reviewed Cancer, Idea Award with funding of $16.0 million. The grant will be issued under grant program 12.420 Military Medical Research and Development. It is expected that 20 total grants will be made.

Timing

Posted Date
May 1, 2024, 12:00 a.m. EDT
Closing Date
Sept. 26, 2024, 12:00 a.m. EDT Past Due
Last Updated
May 1, 2024, 11:08 a.m. EDT
Version
1
Archive Date
Oct. 26, 2024

Eligibility

Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Award Sizing

Ceiling
Not Listed
Floor
Not Listed
Estimated Program Funding
$16,000,000
Estimated Number of Grants
20

Contacts

Contact
Jamie Shortall Grant Officer
Contact Email
help@ebrap.org   Profile
Email Description
CDMRP Help Desk
Contact Phone
(301) 619-2393

Documents

Posted documents for HT942524PRCRPIA

Grant Awards

Grants awarded through HT942524PRCRPIA

Incumbent or Similar Grants

Grants similar to HT942524PRCRPIA

Similar Active Opportunities

Open grant opportunities similar to HT942524PRCRPIA